Sajad Hasanzadeh
Overview
Explore the profile of Sajad Hasanzadeh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
65
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Badali E, Goodarzi A, Khodayari H, Khodayari S, Habibi A, Hasanzadeh S, et al.
J Biomater Appl
. 2022 May;
37(3):502-516.
PMID: 35603878
Biocompatible electrospun fiber comprising bioactive substrates has potential to implant into the wound site as a reliable therapeutic approach in tissue regeneration. Here, electrospun polyvinyl alcohol conjugated tyramine (PVA-Tyr) and...
2.
Mazloomirad F, Hasanzadeh S, Sharifi A, Nikbakht G, Roustaei N, Khoramrooz S
BMC Pulm Med
. 2021 Dec;
21(1):408.
PMID: 34886838
Background: Hospital-acquired pneumonia (HAP) is the second most common nosocomial infection in intensive care units (ICUs). The present study aims to determine the prevalence of pathogenic bacteria, their biofilm formation,...
3.
Keshavarz F, Ghalamfarsa F, Javdansirat S, Hasanzadeh S, Azizi A, Sabz G, et al.
Virusdisease
. 2021 Oct;
32(4):681-689.
PMID: 34631971
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), is a new virus that emerged in China and immediately spread around the world. Evidence has been...
4.
Masjedi A, Ahmadi A, Atyabi F, Farhadi S, Irandoust M, Khazaei-Poul Y, et al.
Int J Biol Macromol
. 2020 Feb;
149:487-500.
PMID: 32004600
The immunosuppressive nature of the tumor microenvironment is a critical problem that should be considered before the design of immunotherapies. Interleukin (IL)-6 and its related downstream molecules such as signal...
5.
Blockage of immune checkpoint molecules increases T-cell priming potential of dendritic cell vaccine
Hassannia H, Chaleshtari M, Atyabi F, Nosouhian M, Masjedi A, Hojjat-Farsangi M, et al.
Immunology
. 2019 Oct;
159(1):75-87.
PMID: 31587253
Dendritic cell (DC) -based cancer immunotherapy is one of the most important anti-cancer immunotherapies, and has been associated with variable efficiencies in different cancer types. It is well-known that tumor...
6.
Ghayumi S, Rohani M, Hasanzadeh S, Sadeghi S, Roozbehi A, Jokar S
Respir Med Case Rep
. 2018 Jul;
24:50-51.
PMID: 29977758
Introduction: Hepatopulmonary syndrome is commonly seen in the patients with chronic liver disease. Acute liver diseases are rarely associated with HPS. We have reported here a case of Transient HPS...
7.
Jafari B, Sabz G, Masnavi E, Panahi R, Jokar S, Roozbehi A, et al.
F1000Res
. 2018 Jun;
7:288.
PMID: 29904593
: Sarcoidosis is a granulomatous disease with unknown cause that can vary from an asymptomatic condition. Almost half of the patients with sarcoidosis have no symptoms. In this article, we...
8.
Hasanzadeh S, Alavi S, Masnavi E, Jokar S, Rohani M
F1000Res
. 2018 May;
7:49.
PMID: 29770208
: Polyarteritis nodosa (PAN) is a vasculitis that affects medium-sized arteries. PAN is a rare disease and requires a high clinical suspicion for diagnosis. PAN and HSP (newly named Immunoglobulin...